Direct visualization and quantification of the anticancer agent, cis-diamminedichloro-platinum(II), in human lung cancer cells using in-air microparticle-induced X-ray emission analysis

Cancer Science

Volumn 99, Issue 5, 2008, Pages 901-904

  Sakurai, Hideyuki ^a   Okamoto, Masahiko ^a   Hasegawa, Masatoshi ^b   Satoh, Takahiro ^c   Oikawa, Masakazu ^c   Kamiya, Tomihiro ^c   Arakawa, Kazuo ^c   Nakano, Takashi ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c JAPAN ATOMIC ENERGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BROXURIDINE; CISPLATIN; LIQUID NITROGEN;

ARTICLE; CANCER CELL; CELL LEVEL; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; DRUG UPTAKE; FREEZE DRYING; HUMAN; HUMAN CELL; IMAGE QUALITY; IMAGING SYSTEM; LUNG ADENOCARCINOMA; LUNG CANCER; MOLECULAR IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGNAL DETECTION; TIME SERIES ANALYSIS; X RAY ANALYSIS; CELL CULTURE; CHEMISTRY; EVALUATION; LUNG TUMOR; METHODOLOGY; SPECTROMETRY;

ANTINEOPLASTIC AGENTS; CISPLATIN; HUMANS; LUNG NEOPLASMS; SPECTROMETRY, X-RAY EMISSION; TUMOR CELLS, CULTURED;

EID: 43649107538     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00755.x     Document Type: Article

References (13)

1. Ajani JA, Moiseyenko VM, Tjulandin S et al. Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: The V-325 Study Group. J Clin Oncol 2007; 25: 3210-16.
2. Eifel PJ. Chemoradiotherapy in the treatment of cervical cancer. Semin Radiat Oncol 2006; 16: 177-85.
3. Schild SE, Bonner JA, Hillman S et al. Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53). J Clin Oncol 2007; 25: 3124-9.
4. Posner MR, Hershock DM, Blajman CR et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007; 357: 1705-15.
5. Boulikas T, Vougiouka M. Cisplatin and platinum drugs at the molecular level. Oncol Rep 2003; 10: 1663-82.
6. Kuo T, Liu F, Chuang C, Wu H, Wang J, Kao A. To predict response chemotherapy using technetium-99m tetrofosmin chest images in patients with untreated small cell lung cancer and compare with p-glycoprotein, multidrug resistance related protein-1, and lung resistance-related protein expression. Nucl Med Biol 2003; 30: 627-32.
7. Godwin AK, Meister A, O'Dwyer PJ, Huang CS, Hamilton TC, Anderson ME. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci 1992; 89: 3070-4.
8. Nakano T, Arakawa K, Sakurai H et al. Research of disease onset mechanism by determining the distribution of intracellular trace elements using an in-air micro-PIXE analyzer system. Int J PIXE 2006; 16: 69-76.
9. Ishii K, Sugimoto A, Tanaka A et al. Elemental analysis of cellular samples by in-air micro-PIXE. Nucl Instr Meth 2001; B181: 448-153.
10. Lobinski R, Moulin C, Ortega R. Imaging and speciation of trace elements in biological environment. Biochimie 2006; 88: 1591-604.
11. Ortega R, Moretto P, Fajac A, Benard J, Llabador Y, Simonoff M. Quantitative mapping of platinum and essential trace metal in cisplatin resistant and sensitive human ovarian adenocarcinoma cells. Cell Mol Biol 1996; 42: 77-88.
12. Ortega R. Intracellular distributions of the anthracycline 4′-iodo-4′-deoxy-doxorubicin and essential trace metals using nuclear microprobe analysis. Polycyclic Aromatic Compd 2000; 21: 99-108.
13. Ortega R, Suda A, Deves G. Nuclear microprobe imaging of gallium nitrate in cancer cell. Nucl Instr Meth 2003; B210: 364-7.